Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

32.43
Delayed Data
As of Apr 29
 -0.91 / -2.73%
Today’s Change
29.20
Today|||52-Week Range
43.85
+0.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues226.5M213.4M219.7M233.4M
 
 
 
 
 
Cost of Goods Sold96.0M88.6M91.7M101.8M
 
 
 
 
 
Depreciation And Amortization22.2M22.3M22.7M22.7M
 
 
 
 
 
 
Operating ExpensesGross Income108.4M102.5M105.3M108.9M
 
 
 
 
 
General Expenses81.3M84.1M79.5M86.2M
 
 
 
 
 
Research And Development17.2M11.3M11.6M10.9M
 
 
 
 
 
Total Operating Expenses199.4M195.0M193.9M210.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income27.1M18.4M25.8M22.6M
 
 
 
 
 
Extraordinary Credit--637.0K160.0K5.1M
 
 
 
 
Extraordinary Charge-15.5M-14.8M-6.7M-88.7M
 
 
 
 
 
Interest Expense On Debt1.9M2.6M2.8M2.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.7M1.6M16.6M-63.3M
 
 
 
 
 
Income Taxes-12.6M-1.9M-3.7M-3.9M
 
 
 
 
 
Net Income-2.9M-267.0K12.9M-59.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.6M51.4M50.7M50.7M
 
 
 
 
 
Shares To Calculate EPS Diluted51.6M51.4M51.2M50.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.01$0.25-$1.17
 
 
 
 
 
EPS Diluted-$0.06-$0.01$0.25-$1.17